Esperion Therapeutics, Inc.
ESPRDelisted Jul 13, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434868
Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Esperion Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 176
- +26 vs. Q1 2024
- Shares held
- 137.0M
- +11.6M (+9.3%) vs. Q1 2024
- Total value
- $304.2M
- −$31.8M (−9.5%) vs. Q1 2024
- New holders
- 56
- 50 more added
- Sold out
- 30
- 26 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ESPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 191 | $646.8M |
| Q1 2026 | 207 | $479.3M |
| Q4 2025 | 201 | $559.6M |
| Q3 2025 | 189 | $286.1M |
| Q2 2025 | 164 | $96.6M |
| Q1 2025 | 187 | $171.5M |
| Q4 2024 | 190 | $277.9M |
| Q3 2024 | 184 | $214.3M |
| Q2 2024 | 176 | $304.2M |
| Q1 2024 | 152 | $336.2M |
| Q4 2023 | 132 | $215.3M |
| Q3 2023 | 123 | $75.9M |
| Q2 2023 | 124 | $103.6M |
| Q1 2023 | 165 | $129.1M |
| Q4 2022 | 164 | $457.6M |
| Q3 2022 | 148 | $425.5M |
| Q2 2022 | 137 | $352.1M |
| Q1 2022 | 132 | $241.2M |
| Q4 2021 | 133 | $268.0M |
| Q3 2021 | 139 | $299.4M |
| Q2 2021 | 142 | $599.4M |
| Q1 2021 | 156 | $805.3M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Esperion Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aristeia Capital LLC | 70,959 | $157.5K | 0.01% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 71,488 | $158.7K | 0.00% | +71,488 | New |
| New York State Common Retirement Fund | 76,500 | $169.8K | 0.00% | +76,500 | New |
| FMR LLC | 77,081 | $171.1K | 0.00% | −28,090−26.7% | Reduced |
| Tocqueville Asset Management L.P. | 77,500 | $172.1K | 0.00% | +37,750+95.0% | Added |
| Advisor Group Holdings, Inc. | 82,580 | $183.3K | 0.00% | +3,950+5.0% | Added |
| Invesco Ltd. | 87,065 | $193.3K | 0.00% | +70,709+432.3% | Added |
| Wolverine Asset Management LLC | 87,384 | $194.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 91,844 | $203.0K | 0.01% | +91,844 | New |
| Corebridge Financial, Inc. | 101,658 | $226.7K | 0.00% | +101,658 | New |
| Wells Fargo & Company | 106,063 | $235.5K | 0.00% | +78,256+281.4% | Added |
| ExodusPoint Capital Management, LP | 106,722 | $237.0K | 0.00% | +23,322+28.0% | Added |
| GTS Securities LLC | 107,109 | $237.8K | 0.00% | +32,713+44.0% | Added |
| Price T Rowe Associates Inc | 107,492 | $239.0K | 0.00% | +72,092+203.6% | Added |
| Virtus ETF Advisers LLC | 113,178 | $251.3K | 0.12% | +113,178 | New |
| Stoneridge Investment Partners LLC | 117,958 | $262.0K | 0.10% | +24,557+26.3% | Added |
| Royal Bank of Canada | 147,076 | $326.0K | 0.00% | +103,280+235.8% | Added |
| Barclays PLC | 155,162 | $344.5K | 0.00% | +50,678+48.5% | Added |
| Pentwater Capital Management LP | 181,290 | $402.5K | 0.01% | +181,290 | New |
| Alliancebernstein L.P. | 182,110 | $404.3K | 0.00% | +182,110 | New |
| CI Private Wealth, LLC | 182,500 | $405.1K | 0.00% | +182,500 | New |
| Alpine Global Management, LLC | 183,922 | $408.3K | 0.07% | +183,922 | New |
| NJ State Employees Deferred Compensation Plan | 195,125 | $433.2K | 0.05% | 00.0% | Unchanged |
| Davidson Kempner Capital Management LP | 222,482 | $489.5K | 0.01% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 236,785 | $514.0K | 0.00% | +49,619+26.5% | Added |
| Parallel Advisors, LLC | 239,000 | $530.6K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 248,092 | $550.8K | 0.00% | −735,251−74.8% | Reduced |
| Rhumbline Advisers | 252,038 | $559.5K | 0.00% | +248,254+6,560.6% | Added |
| Highbridge Capital Management LLC | 254,265 | $564.5K | 0.02% | +254,265 | New |
| Prelude Capital Management, LLC | 270,889 | $601.4K | 0.05% | +242,926+868.7% | Added |
| Marex Group plc | 275,000 | $610.5K | 0.02% | +100,000+57.1% | Added |
| Headlands Technologies LLC | 276,260 | $613.3K | 0.07% | +276,260 | New |
| Pinnacle Associates Ltd | 281,299 | $624.5K | 0.01% | −3,905−1.4% | Reduced |
| CWM Advisors, LLC | 341,223 | $757.5K | 0.09% | +341,223 | New |
| Graham Capital Management, L.P. | 341,890 | $759.0K | 0.03% | +341,890 | New |
| Wellington Management Group LLP | 361,424 | $802.4K | 0.00% | +597+0.2% | Added |
| XTX Topco Ltd | 364,681 | $809.6K | 0.07% | +321,859+751.6% | Added |
| D. E. Shaw & Co., Inc. | 382,488 | $849.1K | 0.00% | −4,760,998−92.6% | Reduced |
| Northern Trust Corp | 405,038 | $899.2K | 0.00% | +96,361+31.2% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 415,900 | $923.3K | 0.00% | +415,900 | New |
| Bank of Montreal | 429,852 | $958.6K | 0.00% | +378,952+744.5% | Added |
| Susquehanna International Group, LLP | 518,958 | $1.15M | 0.00% | −1,526,811−74.6% | Reduced |
| Charles Schwab Investment Management Inc | 554,914 | $1.23M | 0.00% | +496,923+856.9% | Added |
| Bank of New York Mellon Corp | 572,323 | $1.27M | 0.00% | +555,382+3,278.3% | Added |
| Jacobs Levy Equity Management, Inc | 595,016 | $1.32M | 0.01% | −109,081−15.5% | Reduced |
| Diametric Capital, LP | 743,842 | $1.65M | 0.90% | +667,058+868.7% | Added |
| Gsa Capital Partners LLP | 813,399 | $1.81M | 0.13% | +364,270+81.1% | Added |
| Schonfeld Strategic Advisors LLC | 847,727 | $1.88M | 0.01% | −99,779−10.5% | Reduced |
| Goldman Sachs Group Inc | 916,011 | $2.03M | 0.00% | −2,448,255−72.8% | Reduced |
| Qube Research & Technologies Ltd | 1,102,648 | $2.45M | 0.00% | −504,664−31.4% | Reduced |
| Parkman Healthcare Partners LLC | 1,144,646 | $2.54M | 0.35% | +1,749+0.2% | Added |
| Bank of America Corp | 1,163,424 | $2.58M | 0.00% | −3,381,836−74.4% | Reduced |
| Platinum Investment Management Ltd | 1,196,526 | $2.66M | 0.11% | −401,016−25.1% | Reduced |
| Renaissance Technologies LLC | 1,421,900 | $3.16M | 0.01% | −694,600−32.8% | Reduced |
| Citadel Advisors LLC | 1,521,777 | $3.38M | 0.00% | −1,840,433−54.7% | Reduced |
| Deutsche Bank AG | 1,532,123 | $3.40M | 0.00% | +1,532,123 | New |
| CenterBook Partners LP | 1,569,459 | $3.48M | 0.22% | +1,569,459 | New |
| Rhenman & Partners Asset Management AB | 1,975,000 | $4.38M | 0.42% | +1,975,000 | New |
| JPMorgan Chase & Co | 2,049,529 | $4.55M | 0.00% | −35,572−1.7% | Reduced |
| Nuveen Asset Management, LLC | 2,272,628 | $5.05M | 0.00% | +2,272,628 | New |
| Whitefort Capital Management, LP | 2,299,121 | $5.10M | 3.15% | +2,299,121 | New |
| Morgan Stanley | 3,328,854 | $7.39M | 0.00% | +1,686,494+102.7% | Added |
| State Street Corp | 3,754,512 | $8.34M | 0.00% | +3,203,263+581.1% | Added |
| Meditor Group Ltd | 3,791,300 | $8.42M | 15.57% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 3,874,300 | $8.60M | 0.02% | +304,600+8.5% | Added |
| Two Sigma Investments, LP | 4,074,961 | $9.05M | 0.02% | +99,401+2.5% | Added |
| Geode Capital Management, LLC | 4,159,705 | $9.24M | 0.00% | +2,406,512+137.3% | Added |
| Marshall Wace, LLP | 4,303,596 | $9.55M | 0.01% | +2,087,635+94.2% | Added |
| Woodline Partners LP | 5,049,808 | $11.2M | 0.11% | −2,872,421−36.3% | Reduced |
| Two Seas Capital LP | 5,735,660 | $12.7M | 2.08% | +1,570,003+37.7% | Added |
| Great Point Partners LLC | 5,791,594 | $12.9M | 2.46% | −2,208,406−27.6% | Reduced |
| Millennium Management LLC | 6,513,932 | $14.5M | 0.01% | +832,188+14.6% | Added |
| Bellevue Group AG | 9,944,064 | $22.1M | 0.36% | 00.0% | Unchanged |
| Vanguard Group Inc | 10,816,762 | $24.0M | 0.00% | +1,990,216+22.5% | Added |
| BlackRock Inc. | 13,983,662 | $31.0M | 0.00% | +11,144,842+392.6% | Added |
| Wasatch Advisors Inc | 16,862,943 | $37.4M | 0.20% | +7,733,296+84.7% | Added |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −13,708,731−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −442,030−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −440,770−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −300,300−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −273,292−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −227,630−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −166,457−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −159,038−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −142,418−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −114,371−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −92,300−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −84,367−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −69,025−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −63,500−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −51,200−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −43,214−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −38,762−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −37,100−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −32,200−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −32,173−100.0% | Sold out |
| Kingsview Wealth Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −23,330−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −18,267−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −13,974−100.0% | Sold out |